The risk environment surrounding gender-affirming care (GAC) is shifting more rapidly in 2026 than at any point in the past decade. Federal policy reversals, conflicting state laws and evolving insurer behavior are reshaping underwriting norms and compliance exposure for healthcare organizations. While public-sector programs have historically been indicators of where commercial carriers may trend, this year’s regulatory changes signal a decisive shift in how GAC will be financed, scrutinized and litigated across the U.S.
Healthcare organizations, especially those offering care to minors, now face heightened uncertainty in rate-setting, coverage terms, documentation standards and legal vulnerability. Proactive preparation is now a strategic imperative.
Why gender-affirming care policy changes matter in 2026
Recent federal actions have materially changed the financial and regulatory landscape for gender-affirming care.
The Office of Personnel Management (OPM) eliminates GAC coverage in Federal Employees Health Benefits (FEHB) plans – effective 2026
OPM has removed all coverage for gender-affirming treatments, including hormonal and surgical interventions for all ages under the FEHB program. This represents one of the most sweeping federal reversals on GAC coverage to date and is viewed by carriers as a directional signal for the commercial market.
CMS authorizes exclusion of GAC from essential health benefits (EHB) – 2026
CMS has finalized rules allowing ACA marketplace insurers to exclude GAC from EHBs. Though not a mandate, this policy authorizes carriers to narrow coverage, implement exclusions, or shift costs to states and individuals.
State laws diverge, creating compliance conflicts
States are increasingly polarized, some restricting or banning GAC for minors, while others explicitly protect access. These laws increasingly conflict with federal nondiscrimination statutes such as ACA §1557 and Title VII, creating direct compliance tensions for providers operating across state lines.
Impact: Collectively, these shifts heighten uncertainty for insurers, resulting in increased scrutiny, pricing adjustments and early movement toward coverage limitations.
How gender-affirming care policy shifts impact healthcare organizations
Underwriting and coverage behavior
Underwriters are now more frequently evaluating:
- Whether an organization provides GAC, particularly to minors
- Behavioral health evaluation and consent standards
- Clinical oversight of hormone and surgical pathways
- Litigation exposure tied to nondiscrimination laws
- Documentation practices demonstrating alignment with recognized standards of care
As insurer appetite changes, organizations offering pediatric GAC may experience:
- Rate increases tied to perceived litigation and regulatory risk
- Coverage limitations or sublimits
- Requests for detailed program documentation
- Potential exclusions, mirroring early precedents from public sector plans
The legal and compliance environment
Healthcare entities now operate within a patchwork of conflicting mandates.
State restrictions vs. federal nondiscrimination protections
Some states prohibit or limit GAC for minors, yet federal civil rights interpretations may categorize GAC denial as sex discrimination under ACA §1557 or Title VII. This conflict exposes organizations to:
- Regulatory audits
- Patient complaints
- Civil rights litigation
Regulatory instability at the federal level
Executive-driven policy shifts have changed agency enforcement priorities, coverage norms and interpretive guidance. With CMS and OPM altering national coverage rules, courts and agencies are already fielding legal challenges from advocacy groups and impacted individuals.
Bottom line: Providers must expect increased scrutiny of access policies, documentation, communication practices and nondiscrimination compliance, especially in pediatric settings.
